Eirini Palaka

Eirini Palaka is a seasoned healthcare professional with extensive experience in global market access and pricing strategies, currently serving as Vice President of Global Market Access at Ipsen since October 2022. Prior roles include Worldwide Market Access Director at Novartis, where Eirini led the successful global launch strategy for Kesimpta®, and Director of Global Oncology Market Access at AstraZeneca, focusing on ENHERTU®. Eirini's career encompasses strategic leadership in pricing and access for groundbreaking therapies across multiple therapeutic areas, with notable achievements in the inclusion of innovative treatments in reimbursement systems such as NRDL in China. Eirini’s educational background includes an MSc in Health Economics from the University of York and a degree in Pharmacy from the University of Bradford, supplemented by leadership training from the University of Oxford.